Clinical Trial Update: Open-label Trial in Parkinson's Disease (PD) [Phase 3]

View source ↗

Summary

AbbVie-sponsored open-label Phase 3 trial in Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: AbbVie | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED